Getty Images and Shutterstock Merger Review Concluded
Getty Images (GETY) and Shutterstock (SSTK) announced that the United States Department of Justice has concluded its review of the companies' proposed merger of equals and the applicable waiting period under the Hart-Scott-Rodino Act has expired, without conditions. The merger transaction is expected to deliver substantial synergies across SG&A and CAPEX following close . Prior to the DOJ's decision, in the United Kingdom, the Competition and Markets Authority issued its interim report on February 19 as part of the ongoing Phase 2 review. Getty Images and Shutterstock are actively engaged with the CMA ahead of the CMA's final decision due by April 19, to further the CMA's understanding of the Editorial market and how the merger enhances the combined company's ability to serve customers, contributors, and partners in a highly competitive marketplace. Based on the merits of the transaction and market realities, Getty Images and Shutterstock remain hopeful that the CMA will reach a conclusion consistent with the DOJ and other regulators around the globe.
Trade with 70% Backtested Accuracy
Analyst Views on GETY
About GETY
About the author

- Acquisition Strategy: Canva's acquisition of startups Cavalry and MangoAI aims to bolster its competitive edge in animation and short video advertising, particularly as Adobe faces market pressures, demonstrating Canva's proactive approach to market changes.
- Technology Integration: Cavalry's animation technology will be integrated into Canva's core products and the Affinity application, enhancing user capabilities in motion graphics while allowing Cavalry to operate independently to meet diverse designer needs.
- Revenue Growth: Canva reported an annualized revenue exceeding $4 billion in 2025, a 36% increase year-over-year, indicating strong growth momentum in a competitive market, despite Adobe's market capitalization reaching $101 billion.
- AI Application Prospects: Canva plans to incorporate MangoAI technology into its Canva Grow advertisement generator, assisting users in analyzing video performance and optimizing content strategies, further enhancing product competitiveness and user experience.
- Merger Approval: The U.S. Department of Justice has approved the $3.7 billion merger proposal between Getty Images and Shutterstock, marking a significant advancement in their global market consolidation that is expected to enhance their competitive positioning.
- Waiting Period Expiration: The applicable waiting period under the Hart-Scott Rodino Act has expired, allowing the two companies to begin merger preparations ahead of the final decision from the UK's Competition and Markets Authority (CMA).
- Market Reaction: Although the merger news initially boosted the stock prices of both companies, Getty Images has now experienced its eighth consecutive day of decline, while Shutterstock's shares have also dipped slightly, indicating market caution regarding the merger's prospects.
- Future Outlook: In a joint statement, both companies expressed optimism regarding the CMA's final decision, hoping it will align with the DOJ and other global regulators, based on the merits of the transaction and market realities.
- Merger Approval: The U.S. Department of Justice has cleared the merger proposal between Getty Images and Shutterstock, marking a significant step towards resource integration and strengthening financial foundations, which is expected to create more investment opportunities in the future.
- Stock Surge: Following the merger announcement, Getty's stock price soared by 32.96% to 98 cents per share, reflecting strong market optimism about the merger's prospects and potentially attracting more investor interest.
- Expected Synergies: The companies anticipate achieving substantial synergies in sales, general and administrative expenses, and capital expenditures post-merger, which will enhance overall operational efficiency and profitability.
- Regulatory Review Progress: While the merger has been approved in the U.S., both companies are still engaging with the U.K. Competition and Markets Authority, hoping to secure final approval by April 19 to ensure a smooth merger process globally.
- Technological Breakthrough: Kraig Biocraft Laboratories' recombinant spider silk technology featured on the cover of National Geographic, showcasing its genetically enhanced silkworm platform, is expected to drive stock price appreciation and attract investor interest.
- Production Scale: The company plans to deploy approximately one million proprietary silkworm eggs in Vietnam, targeting up to 10 metric tons of cocoons per month, which would make KBLB only the second company in history to achieve sustained commercial production from a transgenic animal platform.
- Market Potential: With confirmation of initial deliveries to global brand partners, KBLB is poised to transition from a research narrative to a specialty materials platform, further solidifying its position in the luxury fashion and performance sportswear markets.
- Acquisition Dynamics: Gilead Sciences announced the acquisition of Arcellx for $115 per share, totaling approximately $7.8 billion, which further consolidates its oncology market position and may enhance the acceptance of related therapies.
- Technology Spotlight: Kraig Biocraft Laboratories' recombinant spider silk technology featured on the cover of the March 2026 issue of National Geographic, showcasing its genetically enhanced silkworm platform, which is expected to attract increased investor interest and enhance the company's market position in biomaterials.
- Production Scale Plans: The company plans to deploy approximately one million proprietary silkworm eggs across three facilities in Vietnam, targeting up to 10 metric tons of cocoons per month, and if successful, this would make Kraig the second company in history to achieve sustained commercial production from a transgenic animal platform.
- Acquisition Deal: Gilead Sciences announced a definitive agreement to acquire Arcellx for $115 per share, representing an implied equity value of approximately $7.8 billion, which will give Gilead full control of a CAR T-cell therapy for relapsed multiple myeloma, further solidifying its oncology market position.
- Revenue Growth: ImmunityBio reported approximately $113 million in net product revenue for ANKTIVA in 2025, reflecting a 700% year-over-year increase, and has expanded regulatory authorization across 33 countries, indicating strong growth potential in the global market.
- Merger Competition Concerns: The UK Competition and Markets Authority (CMA) stated that the proposed merger between Getty Images (GETY) and Shutterstock (SSTK) may reduce competition in the supply of editorial content in the region, although global stock content supply remains unaffected, highlighting regulatory vigilance over market concentration.
- Company Disagreement: Getty expressed disappointment with the CMA's provisional findings, arguing that the analysis does not accurately reflect the UK market's composition or the level of regional competition, indicating the company's ongoing confidence in the merger and potential efforts to secure regulatory approval.
- Transaction Scale: The merger is valued at $3.7 billion and has been under review by the CMA since August last year, following its announcement in January 2025, illustrating the complexity of regulatory scrutiny and the stringent oversight of large transactions.
- Poor Stock Performance: Over the past 12 months, GETY has lost more than two-thirds of its value, while SSTK has declined by over 40%, reflecting market concerns about the future prospects of both companies, which may impact merger negotiations and the final outcome.









